Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Reporter Online.
Press releases published on July 8, 2025
Progress on share buyback programme
GlobeNewswire
·
July 8, 2025
Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 2 May 2025, in total 2,710,019 shares were repurchased during the week of 30 June 2025 up to and including 04 July 2025. The …
Company name change to Amaroq Ltd.
GlobeNewswire
·
July 8, 2025
Reykjavík, July 08, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Company name change to Amaroq Ltd. TORONTO, ONTARIO - 08 July, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development …
Vallourec Secures Two OCTG Contracts in Iraq with CNOOC and with PetroChina
GlobeNewswire
·
July 8, 2025
Press Release VALLOUREC SECURES TWO OCTG CONTRACTS IN IRAQ WITH CNOOC AND WITH PETROCHINA Meudon (France), July 8, 2025 – Vallourec, a world leader in premium seamless tubular solutions, has secured two contracts to supply Oil Country Tubular Goods (OCTG) …
VALLOUREC REMPORTE DEUX CONTRATS OCTG EN IRAK AVEC CNOOC ET AVEC PETROCHINA
GlobeNewswire
·
July 8, 2025
Communiqué de presse VALLOUREC REMPORTE DEUX CONTRATS OCTG EN IRAK AVEC CNOOC ET AVEC PETROCHINA Meudon (France), le 8 juillet 2025 – Vallourec, un leader mondial des solutions tubulaires premium sans soudure, a remporté deux contrats pour la fourniture de …
Basilea erhält im Rahmen ihrer BARDA-Vereinbarung USD 39 Mio. für die weitere Entwicklung der neuen Antipilzmittel Fosmanogepix und BAL2062
GlobeNewswire
·
July 8, 2025
Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 08. Juli 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patientinnen und Patienten zu helfen, die an schweren …
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
GlobeNewswire
·
July 8, 2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal …
Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement
GlobeNewswire
·
July 8, 2025
DANVILLE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the “Company”) announced today that it filed a supplement to its definitive proxy statement, originally filed with the Securities and Exchange Commission …